Malignant Liver Tumors Current and Emerging Therapies Third Edition by Pierre Alain Clavien, Stefan Breitenstein, Jacques Belghiti, Ravi S Chari, Josep M Llovet, Chung Mau Lo, Michael A Morse, Tadatoshi Takayama, Jean Nicolas Vauthey ISBN 1405179767 9781405179768

Malignant Liver Tumors Current and Emerging Therapies Third Edition by Pierre-Alain Clavien, Stefan Breitenstein, Jacques Belghiti, Ravi S. Chari, Josep M. Llovet, Chung-Mau Lo, Michael A. Morse, Tadatoshi Takayama, Jean-Nicolas Vauthey – Ebook PDF Instant Download/Delivery: 1405179767, 9781405179768

Full download Malignant Liver Tumors Current and Emerging Therapies Third Edition after payment

 

Product details:

ISBN 10: 1405179767

ISBN 13: 9781405179768 

Author: Pierre-Alain Clavien, Stefan Breitenstein, Jacques Belghiti, Ravi S. Chari, Josep M. Llovet, Chung-Mau Lo, Michael A. Morse, Tadatoshi Takayama, Jean-Nicolas Vauthey

This comprehensive and critical review of current and established treatment modalities for malignant liver tumors is designed to help you sort through the proliferation of competitive approaches and choose the best treatment options for your patient. Dr. Clavien and his contributors consider all the options – radiological, surgical, pharmaceutical, and emerging/novel therapies – and help you find the best single or combined therapy.

Building on the success of the previous edition, this extremely thorough revision:

• features a new section on Guidelines for Liver Tumors, where you will find specific strategies for treating common liver malignancies; the guidelines were prepared by the Associate Editors and take into account national and international society guidelines
• reflects actual practice by taking a multidisciplinary approach, with contributions from international experts who have extensive experience with this patient population
• achieves comprehensive and balanced coverage by having each chapter reviewed by the Editor, Deputy Editor, two Associate Editors, and at least one external reviewer
• includes 16 new chapters that cover liver anatomy, histologic changes in the liver, epidemiology and natural history of HCC, CCC and colorectal liver metastases, strategies of liver resection, and economic aspects as well as novel therapies
• facilitates the kind of daily interaction among hepatologists, hepatic surgeons, medical oncologists, radiotherapists, and interventional radiologists that is essential when treating patients with complex liver malignancies

In 44 chapters organized into six major sections, the book covers the full range of liver tumors. The perfect blend of evidence and experience, Malignant Liver Tumors: Current and Emerging Therapies, 3^rd Edition, illuminates the path to better patient care. 

Table of contents:

Section 1: Introduction

• Chapter 1: From Promethean to Modern Times

• Chapter 2: Hepatic Anatomy and Terminology

Section 2: Epidemiology and Diagnosis

• Chapter 3: Histology and Pathology of Normal and Diseased Liver

• Chapter 4: Pathology of Primary and Secondary Malignant Liver Tumors

• Chapter 5: Epidemiology, Etiology, and Natural History of Hepatocellular Carcinoma

• Chapter 6: Epidemiology, Etiology, and Natural History of Cholangiocarcinoma

• Chapter 7: Epidemiology, Etiology, and Natural History of Colorectal Liver Metastases

• Chapter 8: Tumor Markers in Primary and Secondary Liver Tumors

• Chapter 9: Modalities for Imaging Liver Tumors

Section 3: Systemic and Regional Therapies

• Chapter 10: Systemic Treatment of Hepatobiliary Tumors

• Chapter 11: External Beam Radiation Therapy for Liver Tumors

• Chapter 12: Internal Radiation Therapy for Liver Tumors

• Chapter 13: Transarterial Embolization for Patients with Hepatocellular Carcinoma

• Chapter 14: Selective Continuous Intra-arterial Chemotherapy for Liver Tumors

• Chapter 15: Isolated Hepatic Perfusion and Percutaneous Hepatic Perfusion

Section 4: Resection, Ablation or Transplantation for Liver Tumors

• Chapter 16: Liver Resection of Primary Tumors: Hepatocellular Carcinoma, Cholangiocarcinoma, and Gallbladder Cancer

• Chapter 17: Liver Resection of Colorectal Liver Metastases

• Chapter 18: Laparoscopic Liver Resection

• Chapter 19: Repeat Resection for Liver Tumors

• Chapter 20: Cryoablation of Liver Tumors

• Chapter 21: Thermal Ablation of Liver Tumors by Radiofrequency, Microwave, and Laser Therapy

• Chapter 22: Ethanol and Other Percutaneous Injection Modalities in the Treatment of Liver Tumors

• Chapter 23: Transplantation for Liver Tumors

• Chapter 24: Preventing Recurrence of Hepatocellular Carcinoma after Curative Resection

Section 5: Guidelines for Liver Tumor Treatment

• Chapter 25: Strategies for Safer Liver Surgery

• Chapter 26: Hepatocellular Carcinoma

• Chapter 27: Cholangiocarcinoma

• Chapter 28: Gallbladder Cancer

• Chapter 29: Colorectal Liver Metastases

Section 6: Emerging Therapies

• Chapter 30: Viral-Based Therapies for Primary and Secondary Liver Cancer

• Chapter 31: Signaling Pathways and Rationale for Molecular Therapies in Hepatocellular Carcinoma

• Chapter 32: Novel Therapies Targeted at Signal Transduction in Liver Tumors

• Chapter 33: Induction of Apoptosis in Liver Tumors

• Chapter 34: Antiangiogenic Agents for Liver Tumors

• Chapter 35: Integrative Oncology: Alternative and Complementary Treatments

Section 7: Special Tumors, Population, and Special Considerations

• Chapter 36: Liver Metastases from Endocrine Tumors

• Chapter 37: Uncommon Primary and Metastatic Liver Tumors

• Chapter 38: Liver Tumors in Special Populations

• Chapter 39: Malignant Liver Tumors in Children

• Chapter 40: Liver Tumors in Asia

• Chapter 41: Liver Tumors in South America

• Chapter 42: Liver Tumors in Africa

• Chapter 43: Anesthetic Management of Liver Surgery

• Chapter 44: Qualitative and Economic Aspects of Liver Surgery

People also search for:

    
malignant liver tumor treatment
    
malignant liver tumor prognosis
    
malignant liver tumors
    
a malignant liver tumor is a
    
a malignant tumor exhibits which manifestation
    
a malignant tumor is a

Tags: Pierre Alain Clavien, Stefan Breitenstein, Jacques Belghiti, Ravi S Chari, Josep M Llovet, Chung Mau Lo, Michael A Morse, Tadatoshi Takayama, Jean Nicolas Vauthey, Malignant, Liver, Tumors, Current, Emerging, Therapies